Huonslab Strengthens HYDIZYME™ Pipeline with Formulation Patent, Targeting 2026 Market Launch Huonslab Co., Ltd., a subsidiary of Huons Global (KOSDAQ:084110), has taken a major step forward in its mission to…
Crossbow Therapeutics Advances Second TCR-Mimetic Cancer Therapy Candidate, CBX-663, Targeting TERT Across Broad Range of Tumors Crossbow Therapeutics, Inc., a biotechnology company pioneering a new class of T-cell receptor (TCR)-mimetic…
Aptar’s Nasal Delivery System Helps Validate Breakthrough Alzheimer’s Treatment in Wake Forest Study In a major advancement for Alzheimer’s research and the evolving field of drug delivery science, AptarGroup, Inc.…
CVS Health Unveils New Workforce Innovation and Talent Center in Columbus to Empower Local Communities Through Job Training and Health Services In a powerful step toward strengthening community health and…
Lantern Pharma Achieves Landmark Complete Response in Heavily Pretreated Lymphoma Patient, Validating AI-Driven Precision Oncology Strategy Lantern Pharma’s LP-284 demonstrates transformative clinical potential in one of the most difficult-to-treat blood…
ReAlta Life Sciences Publishes Preclinical Data Showing RLS-0071 Reduces Brain Inflammation in Neonatal Hypoxic-Ischemic Encephalopathy Model ReAlta Life Sciences, Inc., a clinical-stage biopharmaceutical company advancing therapies that rebalance the body’s…
YourChoice Therapeutics Advances Male Contraception with Second Nature Portfolio Publication Showcasing Human Trial Data for YCT-529 YourChoice Therapeutics, Inc., a clinical-stage biopharmaceutical company pioneering the development of hormone-free contraceptive solutions,…
Charles River Teams Up with Elly’s Team to Accelerate Gene Therapy for Ultra-Rare NEDAMSS Disorder Charles River Laboratories International, Inc. (NYSE: CRL), a global leader in early-stage drug development and…
Alloy Therapeutics and KSAC Forge Strategic Alliance to Propel Global Growth of Japanese Life Science Startups Alloy Therapeutics Co. Ltd. (“Alloy Japan”) has entered into a strategic Memorandum of Understanding…
Takeda Gains FDA 510(k) Clearance for HyHub™ and HyHub™ Duo to Enhance HYQVIA® Administration Experience for Patients with Primary Immunodeficiency and CIDP Takeda (TSE:4502/NYSE:TAK), a global biopharmaceutical leader, announced that…
WHO Strongly Condemns Attacks on Staff Shelter and Warehouse in Gaza as Humanitarian Health Operations Reach Breaking Point The World Health Organization (WHO) has issued a forceful condemnation of recent…
WuXi Biologics Achieves Major Regulatory Milestone with FDA Pre-License Inspection Clearance for Five Facilities, Including First Commercial Pre-Filled Syringe Site WuXi Biologics (HKEX: 2269), a global leader in Contract Research,…